Archives : Staff

Dr. Pierre-Emmanuel Gerard

Dr. Gerard is a Medical Doctor (Nice, FR; Cambridge, UK) and holds an MBA from HEC Business School (Paris, FR). Prior to founding BIOMUNEX, Dr. Gerard acted as a Partner in international strategy consulting companies for 6 years (AEC Partners, IMS Health). In this position, he advised managing directors and managers from leading pharma and biotech companies on key strategic decisions. Dr. Gerard also created two successful healthcare companies. Prior to that, Dr. Gerard was a senior corporate executive in…

Dr. Eugene Zhukovsky

Prior to joining BIOMUNEX as Chief Scientific Officer in January 2015, Dr. Zhukovsky was Chief Scientific Officer of Affimed Therapeutics since 2011. He has more than 20 years professional experience in the field of biotherapeutics research and development. Previously, he was a Senior Research Fellow in the Biotherapeutics Department at Boehringer Ingelheim Pharmaceuticals, Inc. Prior to that, Dr. Zhukovsky was an Associate Director at Xencor, Inc. where he led translational research efforts resulting in several therapeutic candidates targeting malignant and…

Geoffroy de Ribains

Mr. de Ribains has 15 years of experience in Life Sciences venture capital investing in pharmaceuticals, medical device, and diagnostics companies. This enabled him to develop broad experience in the financing of medical innovations, assessment of technologies and products, and design of valorization strategies. Thus Mr. de Ribains gained strong expertise in the financial and development strategies for biotech start-ups. Until recently Mr. de Ribains served for 10 years at Edmond de Rothschild Investment Partners where he was responsible for…

Dr. Olivier Léger

Dr. Olivier Léger holds a PhD in Molecular Immunology, from the University of London (UK), at Institute of Cancer research (Sutton, UK). Dr. Léger is an experienced antibody engineer with over 20 years of accomplishments in research, research management, project management for discovery project teams, intellectual property, lead discovery and preclinical development in biotech and pharma companies. For these last 15 years, Dr. Léger served as Antibody engineering director in Pierre Fabre, NovImmune, as well as Merck Serono. Dr. Léger…